Results for NYT Clinical Trials
F.D.A. Clears Johnson & Johnson’s Shot, the Third Vaccine for U.S. F.D.A. Clears Johnson & Johnson’s Shot, the Third Vaccine for U.S. Reviewed by Divyansh Saxena on February 28, 2021 Rating: 5
F.D.A. Expert Panel Endorses Johnson & Johnson’s Vaccine F.D.A. Expert Panel Endorses Johnson & Johnson’s Vaccine Reviewed by Divyansh Saxena on February 27, 2021 Rating: 5
With Vaccine Delay, Biden Warns of Uncertain End to Pandemic With Vaccine Delay, Biden Warns of Uncertain End to Pandemic Reviewed by Divyansh Saxena on February 20, 2021 Rating: 5
C.D.C. Eases Coronavirus Vaccine Rules for ‘Exceptional Circumstances’ C.D.C. Eases Coronavirus Vaccine Rules for ‘Exceptional Circumstances’ Reviewed by Divyansh Saxena on January 23, 2021 Rating: 5
As Rollout Falters, Scientists Debate New Vaccination Tactics As Rollout Falters, Scientists Debate New Vaccination Tactics Reviewed by Divyansh Saxena on January 04, 2021 Rating: 5
Two Companies Restart Virus Trials in U.S. After Safety Pauses Two Companies Restart Virus Trials in U.S. After Safety Pauses Reviewed by Divyansh Saxena on October 24, 2020 Rating: 5
Health Official Tries to Reassure Public That Science Will Set Vaccine Approval Health Official Tries to Reassure Public That Science Will Set Vaccine Approval Reviewed by Divyansh Saxena on September 10, 2020 Rating: 5
Subscribe to: Posts ( Atom )

Gallery

ads
Powered by Blogger.